---
title: "Keytruda (pembrolizumab) in high-risk early-stage triple-negative breast cancer: medical information"
description: "Questions on Keytruda (pembrolizumab) in high-risk early-stage triple-negative breast cancer, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Indication, Pharmacology, Clinical trials, Safety, Specific populations, Dosing and administration, and 3 further topics. 28 questions quoted from 8 sources."
canonical: "https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Keytruda (pembrolizumab) in high-risk early-stage triple-negative breast cancer: medical information

Manufacturer: Merck Sharp & Dohme LLC  
Prescribing information: [Keytruda](https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf)

## [Indication](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/indication)

- [What is KEYTRUDA (pembrolizumab) approved for in early-stage triple-negative breast cancer?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/indication#keytruda-early-tnbc-indication)
- [Can KEYTRUDA QLEX (subcutaneous pembrolizumab) be used instead of IV KEYTRUDA for early-stage TNBC?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/indication#keytruda-qlex-substitution)
- [What is the generic name of KEYTRUDA?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/indication#keytruda-generic-name)
- [Does PD-L1 expression affect KEYTRUDA eligibility in early-stage TNBC?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/indication#keytruda-pd-l1-expression)

## [Pharmacology](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/pharmacology)

- [How does KEYTRUDA work (mechanism of action)?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/pharmacology#keytruda-mechanism)
- [What is the half-life of KEYTRUDA?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/pharmacology#keytruda-half-life)
- [What are the ingredients in KEYTRUDA?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/pharmacology#keytruda-ingredients)

## [Clinical trials](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials)

- [Who was eligible for the KEYTRUDA KEYNOTE-522 trial?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-early-tnbc-eligibility)
- [What chemotherapy was given with KEYTRUDA in KEYNOTE-522?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-kn522-regimen)
- [Does the KEYTRUDA benefit come from treatment before or after surgery (KEYNOTE-522)?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-phase-contribution)
- [What were baseline characteristics in the KEYTRUDA KEYNOTE-522 trial?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-kn522-baseline)
- [How often did KEYTRUDA plus chemotherapy leave no invasive cancer at surgery (KEYNOTE-522)?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-pcr-results)
- [What was KEYTRUDA event-free survival in KEYNOTE-522?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-efs-results)
- [Does KEYTRUDA with chemotherapy lower the risk of death in early-stage TNBC (KEYNOTE-522)?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-os-results)
- [What are the limitations of KEYTRUDA KEYNOTE-522 survival subgroup results?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/clinical-trials#keytruda-subgroup-caution)

## [Safety](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/safety)

- [What are KEYTRUDA side effects with chemotherapy in early-stage TNBC (KEYNOTE-522)?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/safety#keytruda-trial-safety)
- [How are KEYTRUDA immune-mediated side effects managed?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/safety#keytruda-immune-mediated-reactions)
- [How does KEYTRUDA cause immune-mediated side effects?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/safety#keytruda-immune-mediated-mechanism)
- [Can KEYTRUDA cause liver problems (immune-mediated hepatitis)?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/safety#keytruda-hepatitis)
- [What lab monitoring does KEYTRUDA require in early-stage TNBC?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/safety#keytruda-tnbc-cortisol-monitoring)

## [Specific populations](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/specific-populations)

- [Can KEYTRUDA be used during pregnancy or breastfeeding?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/specific-populations#keytruda-pregnancy-lactation)

## [Dosing and administration](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/dosing-and-administration)

- [What is the KEYTRUDA dose for high-risk early-stage TNBC?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/dosing-and-administration#keytruda-early-tnbc-dosing)
- [Can the KEYTRUDA dose be reduced for side effects?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/dosing-and-administration#keytruda-dose-modifications)

## [Storage and supply](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/storage-and-supply)

- [How is KEYTRUDA stored, including after dilution?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/storage-and-supply#keytruda-storage)

## [Access and coverage](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/access-and-coverage)

- [What are the NDC codes for KEYTRUDA?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/access-and-coverage#keytruda-ndc)
- [Is there a KEYTRUDA patient support program?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/access-and-coverage#keytruda-patient-support)
- [Who can answer KEYTRUDA reimbursement and copay assistance questions?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/access-and-coverage#keytruda-reimbursement-copay-support)

## [Guidelines](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/guidelines)

- [Does NCCN recommend KEYTRUDA for early-stage triple-negative breast cancer?](https://www.evicenter.com/medical-information/keytruda--high-risk-early-stage-triple-negative-breast-cancer/guidelines#keytruda-nccn-recommendation)
